| # | Drug | Count |
|---|---|---|
| 0 | VALPROIC ACID | 10 |
| 1 | RITUXIMAB | 8 |
| 2 | CISPLATIN | 7 |
| 3 | ELTROMBOPAG | 7 |
| 4 | ELTROMBOPAG OLAMINE | 7 |
| 5 | ROMIPLOSTIM | 7 |
| 6 | BEVACIZUMAB | 6 |
| 7 | CARBOPLATIN | 6 |
| 8 | CYCLOPHOSPHAMIDE | 6 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | ALDESLEUKIN | 2 | 0.0016 |
| 2 | ATENOLOL AND CHLORTHALIDONE | 1 | 0.0013 |
| 3 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 4 | ROMIPLOSTIM | 7 | 0.0005 |
| 5 | DANAZOL | 1 | 0.0004 |
| 6 | VALPROIC ACID | 10 | 0.0003 |
| 7 | ELTROMBOPAG OLAMINE | 7 | 0.0003 |
| 8 | TRETINOIN | 2 | 0.0002 |
| 9 | CLOMIPRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Mood Stabilizer [EPC] | 12 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | Anti-epileptic Agent [EPC] | 10 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 4 | Atypical Antipsychotic [EPC] | 7 |
| 5 | Microtubule Inhibitor [EPC] | 7 |
| 6 | Platinum-based Drug [EPC] | 7 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 7 |
| 8 | Alkylating Drug [EPC] | 6 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 7 | 0.0005 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Mood Stabilizer [EPC] | 12 | 0.0001 |
| 7 | Anti-epileptic Agent [EPC] | 10 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 | 0.0000 |